4.7 Article

Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

Anna Kathrin Stueven et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Endocrinology & Metabolism

Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets

E. T. Aristizabal Prada et al.

ENDOCRINE CONNECTIONS (2018)

Article Endocrinology & Metabolism

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines

Samantha Exner et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Article Medicine, Research & Experimental

miR-221 targets HMGA2 to inhibit bleomycin-induced pulmonary fibrosis by regulating TGF-β1/Smad3-induced EMT

Yi-Chun Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)

Article Endocrinology & Metabolism

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1

Timon Vandamme et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Review Gastroenterology & Hepatology

Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy

Kjell E. Oberg et al.

GASTROENTEROLOGY (2010)